Protoporphyrin IX-loaded magnetoliposomes as a potential drug delivery system for photodynamic therapy: Fabrication, characterization and in vitro study

Photodiagnosis and Photodynamic Therapy

Volumn 13, Issue , 2016, Pages 81-90

  Basoglu, Harun ^a   Bilgin, Mehmet Dincer ^b   Demir, Mustafa Muammer ^c  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^b ADNAN MENDERES UNIVERSITY   (Turkey)

^c IZMIR INSTITUTE OF TECHNOLOGY   (Turkey)

Author keywords

Iron oxide nanoparticles; Magnetoliposomes; MCF 7 cells; Photodynamic therapy; Protoporphyrin IX

Indexed keywords

LIPOSOME; MACROGOL 2000; MAGNETOLIPOSOME; PROTOPORPHYRIN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; DELAYED RELEASE FORMULATION; MAGNETITE NANOPARTICLE; NANOCAPSULE; PHOTOSENSITIZING AGENT;

ARTICLE; BIOCOMPATIBILITY; CELL VIABILITY; CONCENTRATION (PARAMETERS); DRUG DELIVERY SYSTEM; ELECTROMAGNETIC FIELD; HEAT SENSITIVITY; HUMAN; HUMAN CELL; HYDRODYNAMICS; IN VITRO STUDY; MCF 7 CELL LINE; MOLECULAR STABILITY; NANOFABRICATION; PARTICLE SIZE; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY; WHITE LIGHT; ZETA POTENTIAL; ADMINISTRATION AND DOSAGE; BODY FLUID; CELL SURVIVAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DIFFUSION; DRUG EFFECTS; DRUG FORMULATION; FEASIBILITY STUDY; MCF-7 CELL LINE; PHOTOCHEMOTHERAPY; PROCEDURES; TREATMENT OUTCOME; ULTRASTRUCTURE;

BODY FLUIDS; CELL SURVIVAL; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG COMPOUNDING; FEASIBILITY STUDIES; HUMANS; LIPOSOMES; MAGNETITE NANOPARTICLES; MCF-7 CELLS; NANOCAPSULES; PARTICLE SIZE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; TREATMENT OUTCOME;

EID: 84960473615     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2015.12.010     Document Type: Article

References (33)

1. Qiu D., An X., Chen Z., Ma X. Microstructure study of liposomes decorated by hydrophobic magnetic nanoparticles. Chem. Phys. Lipids 2012, 165:563-570.
2. Samadikhah H.R., Majidi A., Nikkhah M., Hosseinkhani S. Preparation, characterization, and efficient transfection of cationic liposomes and nanomagnetic cationic liposomes. Int. J. Nanomed. 2011, 6:2275-2283.
3. Pradhan P., Giri J., Rieken F., Koch C., Mykhaylyk O., Doblinger M., et al. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. J. Controll. Release 2010, 142:108-121.
4. Bothun G.D., Lelis A., Chen Y., Scully K., Anderson L.E., Stoner M.A. Multicomponent folate-targeted magnetoliposomes: design, characterization, and cellular uptake. Nanomed. Nanotechnol. Biol. Med. 2011, 7:797-805.
5. Garnier B., Tan S., Miraux S., Bled E., Brisson A.R. Optimized synthesis of 100 nm diameter magnetoliposomes with high content of maghemite particles and high MRI effect. Contrast Media Mol. Imaging 2012, 7:231-239.
6. Faria M.R., Cruz M.M., Goncalves M.C., Carvalho A., Feio G., Martins M.B. Synthesis and characterization of magnetoliposomes for MRI contrast enhancement. Int. J. Pharm. 2013, 446:183-190.
7. De Cuyper M., Soenen S.J., Coenegrachts K., Beek L.T. Surface functionalization of magnetoliposomes in view of improving iron oxide-based magnetic resonance imaging contrast agents: anchoring of gadolinium ions to a lipophilic chelate. Anal. Biochem. 2007, 367:266-273.
8. Soenen S.J., De Cuyper M. How to assess cytotoxicity of (iron oxide-based) nanoparticles: a technical note using cationic magnetoliposomes. Contrast Media Mol. Imaging 2011, 6:153-164.
9. Bilgin M.D., Elcin A.E., Elcin Y.M. Topical use of liposomal copper palmitate formulation blocks porphyrin-induced photosensitivity in rats. J. Photochem. Photobiol. B 2005, 80:107-114.
10. Ackroyd R., Kelty C., Brown N., Reed M. The history of photodetection and photodynamic therapy. Photochem. Photobiol. 2001, 74:656-669.
11. Chatterjee D.K., Fong L.S., Zhang Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv. Drug Deliv. Rev. 2008, 60:1627-1637.
12. Sharman W.M., Allen C.M., van Lier J.E. Photodynamic therapeutics: basic principles and clinical applications. Drug Discov. Today 1999, 4:507-517.
13. O'Connor A.E., Gallagher W.M., Byrne A.T. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem. Photobiol. 2009, 85:1053-1074.
14. Dolmans D.E., Kadambi A., Hill J.S., Flores K.R., Gerber J.N., Walker J.P., et al. Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy. Cancer Res. 2002, 62:4289-4294.
15. Fadel M., Kassab K., Fadeel D.A. Zinc phthalocyanine-loaded PLGA biodegradable nanoparticles for photodynamic therapy in tumor-bearing mice. Lasers Med. Sci. 2010, 25:283-292.
16. Ricci-Junior E., Marchetti J.M. Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use. Int. J. Pharm. 2006, 310:187-195.
17. Fayter D., Corbett M., Heirs M., Fox D., Eastwood A. A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin. NIHR Health Technology Assessment programme: Executive Summaries 2010, 1-129. NIHR Evaluation, Trials and Studies Coordinating Centre (UK), Southampton (UK).
18. Cabuy E. Photodynamic therapy in cancer treatment, Reliable cancer therapies. Energy Based Ther. 2012, 1-54.
19. Inamura I., Uchida K. Association behavior of protoporphyrin IX in water and aqueous poly(N-vinylpyrrolidone) solutions. Interaction between protoporphyrin IX and poly(N-vinylpyrrolidone). Bull. Chem. Soc. Jpn. 1991, 64:2005-2007.
20. Liu Q., Wang X., Wang P., Qi H., Zhang K., Xiao L. Sonodynamic effects of protoporphyrin IX disodium salt on isolated sarcoma 180 cells. Ultrasonics 2006, 45:56-60.
21. Scolaro L.M., Castriciano M., Romeo A., Patane S., Cefali E., Allegrini M. Aggregation behavior of protoporphyrin IX in aqueous solutions: clear evidence of vesicle formation. J. Phys. Chem. B. 2002, 106(10):2453-2459.
22. Gandara L., Sandes E., Di Venosa G., Prack Mc Cormick B., Rodriguez L., Mamone L., et al. The natural flavonoid silybin improves the response to photodynamic therapy of bladder cancer cells. J. Photochem. Photobiol. B 2014, 133:55-64.
23. Mohammadi Z., Sazgarnia A., Rajabi O., Soudmand S., Esmaily H., Sadeghi H.R. An in vitro study on the photosensitivity of 5-aminolevulinic acid conjugated gold nanoparticles. Photodiagn. Photodyn. Ther. 2013, 10:382-388.
24. Vlaskou D., Mykhaylyk O., Krötz F., Hellwig N., Renner R., Schillinger U., et al. Magnetic and acoustically active lipospheres for magnetically targeted nucleic acid delivery. Adv. Funct. Mater. 2010, 20:3881-3894.
25. Frascione D., Diwoky C., Almer G., Opriessnig P., Vonach C., Gradauer K., et al. Ultrasmall superparamagnetic iron oxide (USPIO)-based liposomes as magnetic resonance imaging probes. Int. J. Nanomed. 2012, 7:2349-2359.
26. Kulshrestha P., Gogoi M., Bahadur D., Banerjee R. In vitro application of paclitaxel loaded magnetoliposomes for combined chemotherapy and hyperthermia. Colloids Surf. B: Biointerfaces 2012, 96:1-7.
27. Soenen S.J., Brisson A.R., De Cuyper M. Addressing the problem of cationic lipid-mediated toxicity: the magnetoliposome model. Biomaterials 2009, 30:3691-3701.
28. Yoon J.H., Yoon H.E., Kim O., Kim S.K., Ahn S.G., Kang K.W. The enhanced anti-cancer effect of hexenyl ester of 5-aminolaevulinic acid photodynamic therapy in adriamycin-resistant compared to non-resistant breast cancer cells. Lasers Surg. Med. 2012, 44:76-86.
29. Sharma S., Jajoo A., Dube A. 5-Aminolevulinic acid-induced protoporphyrin-IX accumulation and associated phototoxicity in macrophages and oral cancer cell lines. J. Photochem. Photobio. B: Biol. 2007, 88:156-162.
30. Smith A.M., Mancini M.C., Nie S. Bioimaging second window for in vivo imaging. Nat. Nanotechnol. 2009, 4:710-711.
31. Fratz E.J., Hunter G.A., Ferreira G.C. Expression of murine 5-aminolevulinate synthase variants causes protoporphyrin IX accumulation and light-induced mammalian cell death. PLoS one 2014, 9:e93078.
32. Tachikawa S., El-Zaria M.E., Inomata R., Sato S., Nakamura H. Synthesis of protoporphyrin-lipids and biological evaluation of micelles and liposomes. Bioorg. Med. Chem. 2014, 22:4745-4751.
33. Temizel E., Sagir T., Ayan E., Isik S., Ozturk R. Delivery of lipophilic porphyrin by liposome vehicles: preparation and photodynamic therapy activity against cancer cell lines. Photodiagn. Photodyn. Ther. 2014, 11:537-545.